Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/21/2014US8865223 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
10/21/2014US8865222 Beta-casein assemblies for enrichment of food and beverages and methods of preparation thereof
10/21/2014US8865221 Swellable and degradable microspheres
10/21/2014US8865217 Oral preparation comprising pioglitazone
10/21/2014US8865213 Modified release pharmaceutical compositions
10/21/2014US8865212 Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
10/21/2014US8865211 Bioadhesive drug formulations for oral transmucosal delivery
10/21/2014US8865210 Stable dosage formulations of imidazolylalkyl-pyridines
10/21/2014US8865209 Combined sublingual and gastro-intestinal delivery method of a liquid medication in a single volume limited dose
10/21/2014US8865208 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle
10/21/2014US8865206 Surface modified multilayered nanostructures for dermal delivery
10/21/2014US8865204 Manufacture of lozenge product with radiofrequency
10/21/2014US8865203 Pharmacokinetics of S-adenosylmethionine formulations
10/21/2014US8865202 Water soluble film for oral administration with instant wettability
10/21/2014US8865201 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant in the manufacture of a medicament for treating female genital disorders
10/21/2014US8865200 Sustained release compositions containing progesterone receptor modulators
10/21/2014US8865198 Method for treating a periodontal disease
10/21/2014US8865197 Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
10/21/2014US8865190 Pharmaceutical compositions for the coordinated delivery of NSAIDs
10/21/2014US8865187 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/21/2014US8865182 Adenoviral-based vectors
10/21/2014US8865181 Extracting method of Antrodia cinnamomea
10/21/2014US8865176 Methods and compositions for generating bioactive assemblies of increased complexity and uses
10/21/2014US8865170 Anti-human CCR7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier
10/21/2014US8865151 MetAP-2 inhibitor polymersomes for therapeutic administration
10/21/2014US8865150 pH-sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
10/21/2014US8865149 Polymeric reagents comprising a ketone or a related functional group
10/21/2014US8865148 Polyesteramide platform for site specific drug delivery
10/21/2014US8865143 Reversely thermo-reversible hydrogel compositions
10/21/2014US8865139 Topical tetracycline compositions
10/21/2014US8865138 Melanin modification compositions and methods of use
10/21/2014US8865134 Chewing gum
10/21/2014US8865130 Methods and compositions for diagnostic and therapeutic targeting of COX-2
10/21/2014US8865032 Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
10/21/2014US8864853 Additive mixture for the bactericidal and anticorrosive additization of fuels
10/21/2014US8864742 Catheter locking composition
10/21/2014US8864699 High citrate dialysate and uses thereof
10/21/2014US8863756 Tobacco chewing gum formulation
10/16/2014US20140309581 Method for treating chronic wounds with an extracellular polymeric substance solvating system
10/16/2014US20140309420 One pot process for preparing pemetrexed disodium
10/16/2014US20140309398 Oligomer-corticosteroid conjugates
10/16/2014US20140309314 Polymeric particles for storage and delivery of active agents
10/16/2014US20140309311 Pharmaceutical Combination
10/16/2014US20140309310 Pharmaceutical Composition for Preventing or Treating Disease with Bone Mass Loss Comprising Diaminodiphenylsulfone or Pharmaceutically Acceptable Salt Thereof
10/16/2014US20140309307 Branched 3-phenylpropionic acid derivatives and their use
10/16/2014US20140309306 Composition for amelioration of hypoalbuminemia
10/16/2014US20140309305 Hypertension reducing composition
10/16/2014US20140309304 Use of pufas for treating skin inflammation
10/16/2014US20140309303 Nitrated-fatty acids modulation of type ii diabetes
10/16/2014US20140309301 Antiviral treatments
10/16/2014US20140309300 Bicyclic Labdane Diterpenes for Use in the Treatment of TRPC6 Associated Diseases
10/16/2014US20140309299 Stabilized Pharmaceutical Preparations in Containers Having Limited Perviousness to Water Vapor
10/16/2014US20140309298 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
10/16/2014US20140309296 Budiodarone formulations
10/16/2014US20140309294 Antioxidant composition
10/16/2014US20140309293 Crystalline form
10/16/2014US20140309291 Compositions and Methods for Increasing Stress Resilience
10/16/2014US20140309287 Oligonucleotide formulation
10/16/2014US20140309286 Modulation of tmprss6 expression
10/16/2014US20140309278 Combination cancer treatments utilizing micrornas and egfr-tki inhibitors
10/16/2014US20140309277 Lipids, lipid compositions, and methods of using them
10/16/2014US20140309276 Pharmaceutical Composition Comprising a Mixture of Carboxylated Oligonucleotides
10/16/2014US20140309275 Sphingosine Analogs, Compositions, and Methods Related Thereto
10/16/2014US20140309274 Lipidic Furan, Pyrrole, and Thiophene Compounds for Treatment of Cancer, Neurological Disorders, and Fibrotic Disorders
10/16/2014US20140309271 Treatment of autistic spectrum disorder
10/16/2014US20140309270 Diagnosis and treatment of a form of autistic spectrum disorder
10/16/2014US20140309269 Diagnosis and treatment of p.r.i.c.e. syndrome
10/16/2014US20140309268 Methods for restoration of histamine balance
10/16/2014US20140309267 Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases
10/16/2014US20140309266 Antimicrobial/adjuvant compounds and methods
10/16/2014US20140309263 Biomarkers of therapeutic responsiveness
10/16/2014US20140309260 Treatment for dopaminergic disorders
10/16/2014US20140309259 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309258 Anti-inflammatory compounds
10/16/2014US20140309257 Topoisomerase inhibitors and methods of making and use as therapeutic agents
10/16/2014US20140309256 Therapeutic Method
10/16/2014US20140309254 Pyrrolopyridine derivatives and their use as crth2 antagonists
10/16/2014US20140309252 Compositions and methods for reducing food cravings
10/16/2014US20140309250 Pharmaceutical Formulations
10/16/2014US20140309248 Substituted indolyl alkyl amino derivatives as inhibitors of histone deacetylase
10/16/2014US20140309247 Systems And Methods For Detecting Scalp Follicular Inflammation In Humans
10/16/2014US20140309246 Methods and use of bifunctional enzyme-building clamp-shaped molecules
10/16/2014US20140309243 Combination
10/16/2014US20140309242 Method for activating AMPK and the use of Adenine
10/16/2014US20140309240 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309239 Extended release formulation of a direct thrombin inhibitor
10/16/2014US20140309238 Fluoralkylcarbonyl-oxadiazoles
10/16/2014US20140309236 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
10/16/2014US20140309235 Heterocyclic compounds and their uses
10/16/2014US20140309233 Syk kinase inhibitors as treatment for malaria
10/16/2014US20140309230 Cyclic Glycyl-2-Allyl Proline Improves Cognitive Performance in Impaired Animals
10/16/2014US20140309229 Methods for selecting and treating cancer in patients with igf-1r/ir inhibitors
10/16/2014US20140309223 Tyrosine kinase inhibitors
10/16/2014US20140309219 N-substituted oxazinopteridines and oxazinopteridinones
10/16/2014US20140309217 Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders
10/16/2014US20140309216 Pharmaceutical compounds
10/16/2014US20140309214 Therapeutical Uses of Eslicarbazepine
10/16/2014US20140309205 Ceftolozane antibiotic compositions
10/16/2014US20140309204 Steroid hormone products and methods for preparing them
10/16/2014US20140309203 Phytoecdysones for use in weight stabilization after a weight-loss diet
1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 7860